Connected diagnostics
PSA, MRI and biopsy are interpreted as one clinical story.
Coordinated prostate cancer diagnostics and treatment
Prostate Cancer Centre
A prostate cancer centre is valuable when it connects imaging, biopsy, pathology, treatment planning and long-term follow-up into one understandable pathway.
Clear information for an informed decision
Important context
Expertise matters at every handover
Prostate cancer decisions depend on several disciplines. Urologists, radiologists, pathologists, radiation oncologists and medical oncologists contribute different evidence to the same case.
A strong centre does more than list technologies. It confirms diagnosis, explains competing options, records functional priorities and creates a follow-up plan before treatment begins.
Treatment comparison
Surveillance, surgery, radiotherapy, focal and systemic options are considered openly.
Continuity
The patient knows who monitors PSA, symptoms, imaging and further decisions.
Who may be suitable?
Suitability cannot be decided from a single PSA value or one line in an MRI report. A urologist needs the complete clinical picture.
Who may be suitable?
- ✓A patient wants a clear second opinion before an irreversible decision.
- ✓A new or uncertain diagnosis needs expert review.
- ✓MRI and biopsy results do not fully agree.
- ✓Several treatment options appear reasonable.
Not every patient needs the same treatment
- !Follow-up responsibilities must be clear before treatment.
- !Urgent symptoms or suspected advanced disease need prompt clinical assessment.
- !A centre should explain limitations, not only benefits.
- !Experience with a device does not replace correct patient selection.
A precise pathway before treatment
Good prostate cancer care connects imaging, pathology and clinical risk. Treatment is chosen only after these pieces agree.
- 1
Treatment decision
Options are compared according to stage, risk, health, priorities and expected side effects.
- 2
Structured follow-up
PSA, imaging and—when indicated—repeat biopsy check how the chosen strategy is working.
- 3
Initial assessment
Medical history, PSA, examination and previous reports are reviewed together.
- 4
High-quality imaging
Multiparametric MRI helps locate suspicious areas and assess local extent.
- 5
Tissue confirmation
Targeted and systematic biopsy provide the diagnosis and grade of the tumour.
What patients usually want to understand
- What follow-up is required and what would trigger additional treatment.
- What the treatment is expected to achieve in this exact risk group.
- How urinary continence, sexual function and recovery may be affected.
- Which alternative options remain available now and later.
Questions worth asking before deciding
- Which areas were sampled at biopsy and do they match the MRI findings?
- What are the realistic short- and long-term side effects in this case?
- How experienced is the centre with the proposed diagnostic or treatment pathway?
- Is the cancer confined to the prostate, and how certain is the staging?
Follow-up is part of treatment
A procedure is only one moment in the care pathway. Regular PSA testing, clinical review and appropriate imaging are needed to identify response, recurrence or a new relevant lesion early.
Frequently asked questions
01How do I prepare for consultation?
Collect original imaging, pathology, PSA history, discharge reports and a medication list.
02What should a prostate cancer centre review?
PSA trend, examination, MRI, biopsy pathology, staging, overall health and the patient’s functional priorities.
03Why is MRI review important?
Image quality and expert interpretation affect lesion localisation, biopsy planning and focal-treatment selection.
04What is a multidisciplinary review?
Specialists from relevant disciplines discuss the case and align diagnosis, risk and treatment options.
05Can a centre offer a second opinion?
Yes. A second review may confirm the original plan or identify reasonable alternatives.
06Does the newest technology mean the best treatment?
No. Technology helps only when the diagnosis, indication and team experience are appropriate.
Bring your results. Leave with a clearer plan.
Uropoint provides specialist urological assessment. Bring PSA results, MRI images and report, biopsy histology and previous medical records to make the consultation as useful as possible.